Vol 9 (May 30, 2025): Annals of Cancer Epidemiology

Original Article 
Evaluation of interim modifications for extended dosing intervals of durvalumab for locally advanced unresectable stage III non-small cell lung cancer during the COVID-19 pandemic
Xiaochen Tai, Caroline E. Muñoz, Jessica Arias, Andrew G. Robinson, M. Sara Kuruvilla, Stephanie Brulé, Munaza Chaudhry, Scott Gavura, Steven Habbous, Nibene Somé, Kelvin K. W. Chan
Annals of Cancer Epidemiology  
2025;
9:
3  
Original Article 
Development of a composite score to assess colorectal cancer risk based on both genetic and environmental factors
Mei Yang, F. Benjamin Zhan, Vagheesh M. Narasimhan
Annals of Cancer Epidemiology  
2025;
9:
2